Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02486562 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis

Study acronym: iCMS
StatusRecruiting
PhaseNot specified
Started2014-11
View on ClinicalTrials.gov ↗
iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their family members (via iConquerMS Kids \& Teens) and MS caregivers (via iConquerMS Caregivers) to participate.

Amendment record

Amended 6 times since 2015-06-29; most recent filed 2025-02-14. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-31.

2025-02-14
Amendment Study Identification, Study Status, Oversight, Study Description, Eligibility v6
2024-04-18
Amendment Study Status v5
2021-07-19
Amendment Study Status, Sponsor/Collaborators v4
2019-07-01
Amendment Study Status, Sponsor/Collaborators v3
2018-01-13
Amendment Study Status, Study Design v2
2016-07-13
Amendment Study Status v1
2015-06-29
Original filing
Trial Details
NCT Number NCT02486562
Lead Sponsor Accelerated Cure Project for Multiple Sclerosis
Collaborators: Patient-Centered Outcomes Research Institute, Ogilvy, Arizona State University
Conditions Multiple Sclerosis
Enrollment 20,000 participants
Start Date 2014-11
Primary Completion 2030-10 (estimated)
Study Completion 2036-10 (estimated)
Updated on ClinicalTrials.gov 2025-02-18